Onxeo to Participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference
Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO), a biopharmaceutical company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announced that the management of the company will hold one-on-one investor meetings at the Guggenheim Securities 4th Annual Boston Healthcare Conference, taking place Tuesday, December 13, 2016 at The InterContinental Boston in Boston, Massachussetts.
By participating in this conference, Onxeo will have the opportunity to meet healthcare-focused investors to further present the company and its promising pipeline.
Investors attending the conference who are interested in meeting with Onxeo management should contact their Guggenheim Securities representative.